Products
FDA approves LENZ Therapeutics' VIZZ for presbyopia
LNZ100, now VIZZ, is the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults.
Business
Topcon acquires Intelligent Retinal Imaging Systems
As part of the
Research
Could oral contraceptives lead to retinal thinning?
Duration of oral contraceptive use mediated the impact on retinal morphology.
Research
New phase 3 data compares efficacy of Lumify PF to Lumify drops for ocular redness reduction
Randomized trial reports favorable outcomes in evaluating the safety and efficacy of the preservative-free brimonidine tartrate (0.025%) formulation.
Research
Current trajectory of global eyecare access unlikely to meet 2030 goal
Study advocates for global efforts to equitably increase spectacle coverage to achieve 2030 goal.
Products
Alcon's TRYPTYR launches to the US market
Company’s first-in-class, prescription-based pharmaceutical features acoltremon, making it the first topical neuromodulator to rapidly increase tear production for DED.
Products
Ziemer USA unveils new CTAK module for GALILEI diagnostic platform
Latest addition to the FDA-cleared diagnostic device combines high-resolution corneal tomography with laser-guided stromal inlay preparation for customized corneal reshaping.
Pipeline
Boehringer partners with Re-Vana on extended-release ophthalmic therapeutics
Collaboration involves photo-crosslinked, biodegradable implants designed to enable continuous, 3-to-12-month drug delivery to treat retinal diseases.
Research
Survey: Women optometrists report higher burnout and stress
Increased job dissatisfaction for women optometrists may be caused by “status level burdening.”
Products
Olleyes introduces remote ophthalmic tech support for VR-VF testing
Developers of the VisuALL VRP now offer visual field testing with on-demand access to certified ophthalmic professionals across the country.
Products
Aetna adds CureSight as medically necessary for amblyopia
Insurance provider is the second in two months to add NovaSight’s digital amblyopia therapy for pediatric patients.
Business
Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes
Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.
Research
Eye2Gene study supports AI analysis of SPECTRALIS platform for IRDs
New research evaluates the use of a deep learning algorithm trained on retinal scans to identify IRD-causing genes and predict patients’ inherited retinal disease.
Legal
National eyecare organizations launch campaign against NEI consolidation
#SeeWhatMatters initiative is a call to action against the proposed restructuring of the National Eye Institute and federal cuts in vision research funding.
Legal
Minnesota passes OD scope of practice expansion legislation
First new scope update in over two decades permits optometrists to administer some in-office injections and removes restrictions on several prescribing capabilities.
Research
Mixed reality glasses may restore partial vision loss in stroke patients
Researchers investigate a new prototype software for commercially-available glasses that enables real-time navigation of a visual environment.
Products
Altris AI launches new app for direct OCT syncing
Altris Sync software syncs directly to OCT devices from eight leading manufacturers, enabling automated OCT file uploading and eliminating the need for manual operation.
Business
Topcon invests in OKKO Health's home vision monitoring platform
The OKKO Health app is available on patients’ digital devices to enable ongoing self-monitoring of macular degeneration.
Business
Clearside exploring options to advance suprachoroidal delivery platform
Company pauses all other research programs, transitions employees to consulting roles, and shares phase 3 plans for wet AMD candidate while focusing on the SCS Microinjector.
Pipeline